Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,792 | 13,709 | 6,106 | 708 | 875 |
| Other current assets | 0 | 0 | 0 | 383 | 242 |
| TOTAL | $22,025 | $13,986 | $6,437 | $1,349 | $1,338 |
| Non-Current Assets | |||||
| PPE Net | 9,404 | 9,544 | 9,713 | 9,886 | 10,059 |
| Intangibles | 356 | 358 | 361 | 363 | 365 |
| Other Non-Current Assets | 63 | 26 | 17 | 21 | 25 |
| TOTAL | $9,824 | $9,929 | $10,091 | $10,270 | $10,448 |
| Total Assets | $31,848 | $23,914 | $16,528 | $11,618 | $11,786 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 16 | 63 | 109 | N/A | N/A |
| Accounts payable and accrued liabilities | 696 | 942 | 988 | 1,410 | 1,371 |
| Accrued Expenses | 62 | 69 | 44 | 53 | 61 |
| Other current liabilities | N/A | N/A | N/A | 1,371 | 1,224 |
| TOTAL | $1,866 | $2,156 | $2,213 | $3,896 | $2,657 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,866 | $2,156 | $2,213 | $3,896 | $2,657 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,665 | 10,654 | 9,073 | 7,423 | 3,854 |
| Common Shares | 11 | 9 | 8 | 4 | 4 |
| Retained earnings | -107,874 | -105,563 | -103,689 | -95,605 | -93,678 |
| TOTAL | $29,982 | $21,758 | $14,315 | $7,722 | $9,130 |
| Total Liabilities And Equity | $31,848 | $23,914 | $16,528 | $11,618 | $11,786 |